RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
44.81
-0.31 (-0.69%)
At close: Nov 20, 2024, 4:00 PM
43.90
-0.91 (-2.03%)
After-hours: Nov 20, 2024, 7:50 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $1.81 billion as of November 21, 2024. Its market cap has increased by 102.35% in one year.
Market Cap
1.81B
Enterprise Value
1.58B
1-Year Change
102.35%
Ranking
Category
Stock Price
$44.81
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $1.81B, an increase of 325.62%. That is a compound annual growth rate of 54.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.81B | 24.90% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MannKind | 1.88B |
| Harmony Biosciences Holdings | 1.87B |
| Patterson Companies | 1.86B |
| Tandem Diabetes Care | 1.83B |
| Azenta | 1.83B |
| Structure Therapeutics | 1.79B |
| Recursion Pharmaceuticals | 1.79B |
| Galapagos NV | 1.78B |